BCL2L11 and Miyoshi myopathy: Analysis of histone modifications at the Bim promoter, and its upstream transcriptional activator, revealed that IGF-1 treatment of MM resulted in an increase of repressive histone methylation marks (H3K9me2) and thus reduced transcription of Bim (9).